Ewing, NJ, United States of America

Scott A Biller


Average Co-Inventor Count = 2.2

ph-index = 17

Forward Citations = 1,347(Granted Patents)


Location History:

  • Lawrenceville, NJ (US) (1988)
  • Ewing, NJ (US) (1989 - 2000)
  • Hopewell, NJ (US) (1998 - 2008)
  • Lexington, MA (US) (2008)

Company Filing History:


Years Active: 1988-2008

Loading Chart...
47 patents (USPTO):Explore Patents

Title: **Scott A Biller: An Innovator in Diabetes and Atherosclerosis Treatments**

Introduction

Scott A Biller is an esteemed inventor based in Ewing, NJ, with an impressive portfolio of 47 patents. His innovative work primarily focuses on methods for treating chronic diseases, specifically diabetes and atherosclerosis, utilizing novel therapeutic approaches.

Latest Patents

Biller's latest contributions to the medical field include two notable patents. The first is a method for treating diabetes employing an aP2 inhibitor, along with a combination of this inhibitor and other antidiabetic agents such as metformin, glyburide, troglitazone, and insulin. This advancement offers promising avenues for managing Type II diabetes and related diseases. The second patent addresses the treatment of atherosclerosis, providing a method that combines an aP2 inhibitor with other antiatherosclerotic agents, including HMG CoA reductase inhibitors like pravastatin. These innovations reflect Biller's commitment to advancing medical science and improving patient outcomes.

Career Highlights

Throughout his career, Scott A Biller has made significant strides in the pharmaceutical industry. He has worked with prominent companies such as E.R. Squibb & Sons, Inc. and Bristol-Myers Squibb Company. His experience in these organizations has been pivotal in shaping his expertise and contributions to the field.

Collaborations

Biller's journey in innovation has seen him collaborate with distinguished professionals, including R Michael Lawrence and David R Magnin. These collaborations have likely enriched his research and development efforts, bringing forth innovative solutions in the medical domain.

Conclusion

Scott A Biller continues to be a driving force in the field of medical innovation. His groundbreaking patents and collaborations highlight his dedication to addressing significant health challenges. As he progresses in his career, the impact of his work is sure to resonate within the medical and scientific communities.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…